Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Exp Lung Res ; 41(4): 189-98, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25844692

RESUMO

PURPOSE: Asthma is associated with reversible airway obstruction, leucocyte infiltration, airways hyperresponsiveness (AHR), and airways remodeling. Fluid accumulation causes pulmonary edema contributing to airways obstruction. We examined the temporal relationship between the late asthmatic response (LAR) following allergen challenge of sensitized guinea-pigs and pulmonary edema measured by magnetic resonance imaging (MRI). MATERIALS AND METHODS: Ovalbumin (OVA) sensitized guinea-pigs received either a single OVA inhalation (acute) or nine OVA inhalations at 48 h intervals (chronic). Airways obstruction was measured as specific airways conductance (sG(aw)) by whole body plethysmography. AHR to inhaled histamine and bronchoalveolar lavage for leucocyte counts were measured 24 h after a single or the final chronic ovalbumin challenges. MRI was performed at intervals after OVA challenge and high-intensity edemic signals were quantified. RESULTS: Ovalbumin caused early bronchoconstriction, followed at 7 h by an LAR and at 24 h AHR and leucocyte influx. The bright-intensity MRI edema signal, peaking at 7 h, was significantly (P < .05) greater after chronic (9.0 ± 0.7 × 10(3) mm(3)) than acute OVA (7.6 ± 0.2 × 10(3) mm(3)). Dexamethasone treatment before acute OVA abolished the AHR and LAR and significantly reduced eosinophils and the bright-intensity MRI edema from 9.1 ± 1.0 to 6.4 ± 0.3 × 10(3) mm(3). CONCLUSION: We show a temporal relationship between edema and the LAR and their parallel reduction, along with eosinophils and AHR, by dexamethasone. This suggests a close causative association between pulmonary edema and impaired airways function.


Assuntos
Alérgenos , Asma/patologia , Pulmão/patologia , Imageamento por Ressonância Magnética , Ovalbumina , Edema Pulmonar/patologia , Animais , Antiasmáticos/farmacologia , Asma/induzido quimicamente , Asma/imunologia , Asma/fisiopatologia , Asma/prevenção & controle , Líquido da Lavagem Broncoalveolar/imunologia , Broncoconstrição , Quimiotaxia de Leucócito , Dexametasona/farmacologia , Modelos Animais de Doenças , Cobaias , Pulmão/efeitos dos fármacos , Pulmão/fisiopatologia , Masculino , Valor Preditivo dos Testes , Edema Pulmonar/induzido quimicamente , Edema Pulmonar/imunologia , Edema Pulmonar/prevenção & controle , Eosinofilia Pulmonar/induzido quimicamente , Eosinofilia Pulmonar/imunologia , Eosinofilia Pulmonar/patologia , Eosinofilia Pulmonar/prevenção & controle , Fatores de Tempo
2.
Drug Discov Today Technol ; 10(3): e343-50, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24050130

RESUMO

Preclinical imaging with magnetic resonance imaging (MRI), computerised tomography (CT), ultrasound (US), positron emission tomography (PET) or single-photon emission computed tomography (SPECT) enable non-invasive measures of tissue structure, function or metabolism in vivo. The technologies can add value to preclinical studies by enabling dynamic pharmacological observations on the same animal and because of possibilities for relatively direct clinical translation. Potential benefits from the application of preclinical imaging should be considered routinely in drug development.


Assuntos
Diagnóstico por Imagem , Avaliação Pré-Clínica de Medicamentos/métodos , Animais , Tratamento Farmacológico , Humanos , Farmacocinética
3.
Clin Sci (Lond) ; 125(12): 555-64, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23725401

RESUMO

The present study investigated the role that imaging could have for assessing lung inflammation in a mouse model of HDM (house dust mite)-provoked allergic inflammation. Inflammation is usually assessed using terminal procedures such as BAL (bronchoalveolar lavage) and histopathology; however, MRI (magnetic resonance imaging) and CT (computed tomography) methods have the potential to allow longitudinal, repeated study of individual animals. Female BALB/c mice were administered daily either saline, or a solution of mixed HDM proteins sufficient to deliver a dose of 12 or 25 µg total HDM protein±budesonide (1 mg/kg of body weight, during weeks 5-7) for 7 weeks. AHR (airway hyper-responsiveness) and IgE measurements were taken on weeks 3, 5 and 7. Following imaging sessions at weeks 3, 5 and 7 lungs were prepared for histology. BAL samples were taken at week 7 and lungs prepared for histology. MRI showed a gradual weekly increase in LTI (lung tissue intensity) in animals treated with HDM compared with control. The 25 µg HDM group showed a continual significant increase in LTI between weeks 3 and 7, the 12 µg HDM-treated group showed a similar rate of increase, and plateaued by week 5. A corresponding increase in AHR, cell counts and IgE were observed. CT showed significant increases in lung tissue density from week 1 of HDM exposure and this was maintained throughout the 7 weeks. Budesonide treatment reversed the increase in tissue density. MRI and CT therefore provide non-invasive sensitive methods for longitudinally assessing lung inflammation. Lung tissue changes could be compared directly with the classical functional and inflammatory readouts, allowing more accurate assessments to be made within each animal and providing a clinically translatable approach.


Assuntos
Modelos Animais de Doenças , Pulmão/diagnóstico por imagem , Hipersensibilidade Respiratória/diagnóstico por imagem , Animais , Biomarcadores , Doença Crônica , Feminino , Estudos Longitudinais , Pulmão/patologia , Imageamento por Ressonância Magnética , Camundongos , Camundongos Endogâmicos BALB C , Pneumonia/diagnóstico por imagem , Pneumonia/patologia , Pyroglyphidae/imunologia , Hipersensibilidade Respiratória/patologia , Mecânica Respiratória , Tomografia Computadorizada por Raios X
4.
Br J Pharmacol ; 169(3): 580-9, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23441756

RESUMO

BACKGROUND AND PURPOSE: Nasal sensory nerves play an important role in symptoms associated with rhinitis triggered by environmental stimuli. Here, we propose that TRPV1 is pivotal in nasal sensory nerve activation and assess the potential of SB-705498 as an intranasal therapy for rhinitis. EXPERIMENTAL APPROACH: The inhibitory effect of SB-705498 on capsaicin-induced currents in guinea pig trigeminal ganglion cells innervating nasal mucosa was investigated using patch clamp electrophysiology. A guinea pig model of rhinitis was developed using intranasal challenge of capsaicin and hypertonic saline to elicit nasal secretory parasympathetic reflex responses, quantified using MRI. The inhibitory effect of SB-705498, duration of action and potency comparing oral versus intranasal route of administration were examined. KEY RESULTS: SB-705498 concentration-dependently inhibited capsaicin-induced currents in isolated trigeminal ganglion cells (pIC50 7.2). In vivo, capsaicin ipsilateral nasal challenge (0.03-1 mM) elicited concentration-dependent increases in contralateral intranasal fluid secretion. Ten per cent hypertonic saline initiated a similar response. Atropine inhibited responses to either challenge. SB-705498 inhibited capsaicin-induced responses by ∼50% at 10 mg·kg⁻¹ (oral), non-micronized 10 mg·mL⁻¹ or 1 mg·mL⁻¹ micronized SB-705498 (intranasal) suspension. Ten milligram per millilitre intranasal SB-705498, dosed 24 h prior to capsaicin challenge produced a 52% reduction in secretory response. SB-705498 (10 mg·mL⁻¹, intranasal) inhibited 10% hypertonic saline responses by 70%. CONCLUSIONS AND IMPLICATIONS: The paper reports the development of a guinea pig model of rhinitis. SB-705498 inhibits capsaicin-induced trigeminal currents and capsaicin-induced contralateral nasal secretions via oral and intranasal routes; efficacy was optimized using particle-reduced SB-705498. We propose that TRPV1 is pivotal in initiating symptoms of rhinitis.


Assuntos
Modelos Animais de Doenças , Mucosa Nasal/efeitos dos fármacos , Sistema Nervoso Parassimpático/efeitos dos fármacos , Parassimpatolíticos/uso terapêutico , Pirrolidinas/uso terapêutico , Rinite Alérgica Perene/tratamento farmacológico , Canais de Cátion TRPV/antagonistas & inibidores , Ureia/análogos & derivados , Administração Intranasal , Administração Oral , Animais , Antialérgicos/administração & dosagem , Antialérgicos/química , Antialérgicos/farmacologia , Antialérgicos/uso terapêutico , Capsaicina/administração & dosagem , Capsaicina/antagonistas & inibidores , Capsaicina/toxicidade , Células Cultivadas , Relação Dose-Resposta a Droga , Composição de Medicamentos , Feminino , Cobaias , Masculino , Mucosa Nasal/inervação , Mucosa Nasal/metabolismo , Sistema Nervoso Parassimpático/metabolismo , Sistema Nervoso Parassimpático/patologia , Parassimpatolíticos/administração & dosagem , Parassimpatolíticos/química , Parassimpatolíticos/farmacologia , Tamanho da Partícula , Pirrolidinas/administração & dosagem , Pirrolidinas/química , Pirrolidinas/farmacologia , Rinite Alérgica , Rinite Alérgica Perene/metabolismo , Rinite Alérgica Perene/patologia , Via Secretória/efeitos dos fármacos , Fármacos do Sistema Sensorial/administração & dosagem , Fármacos do Sistema Sensorial/antagonistas & inibidores , Fármacos do Sistema Sensorial/toxicidade , Canais de Cátion TRPV/metabolismo , Gânglio Trigeminal/efeitos dos fármacos , Gânglio Trigeminal/metabolismo , Gânglio Trigeminal/patologia , Ureia/administração & dosagem , Ureia/química , Ureia/farmacologia , Ureia/uso terapêutico
5.
IEEE Trans Med Imaging ; 25(12): 1617-26, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17167996

RESUMO

Recent innovations in drug therapies have made it highly desirable to obtain sensitive biomarkers of disease progression that can be used to quantify the performance of candidate disease modifying drugs. In order to measure potential image-based biomarkers of disease progression in an experimental model of rheumatoid arthritis (RA), we present two different methods to automatically quantify changes in a bone in in-vivo serial magnetic resonance (MR) images from the model. Both methods are based on rigid and nonrigid image registration to perform the analysis. The first method uses segmentation propagation to delineate a bone from the serial MR images giving a global measure of temporal changes in bone volume. The second method uses rigid body registration to determine intensity change within a bone, and then maps these into a reference coordinate system using nonrigid registration. This gives a local measure of temporal changes in bone lesion volume. We detected significant temporal changes in local bone lesion volume in five out of eight identified candidate bone lesion regions, and significant difference in local bone lesion volume between male and female subjects in three out of eight candidate bone lesion regions. But the global bone volume was found to be fluctuating over time. Finally, we compare our findings with histology of the subjects and the manual segmentation of bone lesions.


Assuntos
Articulação do Tornozelo/patologia , Artrite Reumatoide/patologia , Aumento da Imagem/métodos , Interpretação de Imagem Assistida por Computador/métodos , Imageamento por Ressonância Magnética/métodos , Reconhecimento Automatizado de Padrão/métodos , Técnica de Subtração , Algoritmos , Animais , Inteligência Artificial , Progressão da Doença , Feminino , Armazenamento e Recuperação da Informação/métodos , Masculino , Ratos , Ratos Endogâmicos Lew , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...